$3,290.00

MIA PaCa-2 SMAD/TGFbeta Reporter (Luc) stable cell line

Catalog number
CL-1475
Description
MIA PaCa-2 SMAD/TGFbeta Reporter (Luc) cells are derived from the human pancreas carcinoma MIA PaCa-2 cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. MIA PaCa-2 cells are widely used to study pancreatic cancer biology and to evaluate the effectiveness of new drugs and targeted therapies for treating pancreatic cancer. MIA PaCa-2 SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGFβ/SMAD signaling pathway.

Product Details

Package Size 2 x 10^6 cells
Parental cell line MIA PaCa-2 cells
Transgenic gene Firefly luciferase
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice
Copyright © 2025, FenicsBIO. All rights reserved.